Purpose: The research aimed to investigate the prevalence of PTSD in newly diagnosed Chinese women with breast cancer and to distinguish a munber of sociodemographic, disease-related and psychosocial factors connected with the severity of PTSD symptom.
Methods: This cross-sectional study recruited 674 newly diagnosed Chinese women with breast cancer at three tertiary level a general hospitals in Chengdu, China between August 2022 and May 2023. And questionnaires about general information, locus of control, social support, coping styles, emotional regulation and PTSD were filled out. Multiple linear regression analysis was applied to probe factors related to PTSD.
Results: The prevalence of PTSD was 13.95%. Significant differences were in PTSD among participants of different ethnicities (t = -2.474,p = 0.017), education levels (F = 8.532,p < 0.001), per capita monthly household income (F = 6.027,p < 0.001), stages of the disease (F = 12.972,p < 0.001). Pearson correlation analysis showed that locus of control, social support, coping style, emotional regulation, and PTSD were significantly correlated. The multiple regression model showed that ethnicity, internality of locus of control, subjective support, negative coping, cognitive reappraisal and expression inhibition can interpret 36% of the variation in PTSD.
Conclusions: The research was one of the early attempts in assessing PTSD symptom in newly diagnosed Chinese women with breast cancer and confirmed some important, possible changeable factors (internality, subjective support, negative coping, cognitive reappraisal and expression inhibition) were related to PTSD, supplying an significant guidance for formulating valid psychosocial interventions for such female population.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ejon.2024.102776 | DOI Listing |
Ann Intern Med
January 2025
Durham VA Health Care System, Durham; and Division of General Internal Medicine, Department of Medicine, Duke University School of Medicine, Durham, North Carolina (K.M.G.).
Background: Tissue-based genomic classifiers (GCs) have been developed to improve prostate cancer (PCa) risk assessment and treatment recommendations.
Purpose: To summarize the impact of the Decipher, Oncotype DX Genomic Prostate Score (GPS), and Prolaris GCs on risk stratification and patient-clinician decisions on treatment choice among patients with localized PCa considering first-line treatment.
Data Sources: MEDLINE, EMBASE, and Web of Science published from January 2010 to August 2024.
J Infect Dev Ctries
December 2024
Family Medicine, Merkezefendi District Health Directorate, Denizli, Turkey.
Introduction: Post-COVID-19 syndrome refers to the occurrence of symptoms lasting more than 4 weeks in individuals who have recovered from COVID-19. This study aims to investigate the post-COVID-19 symptoms in healthcare professionals.
Methodology: This descriptive study included 166 healthcare professionals who had tested positive for COVID-19 via PCR at least four weeks prior and subsequently presented to the Family Medicine Clinic at Pamukkale University Training and Research Hospital.
Ir J Med Sci
January 2025
Department of Breast Surgery, St. Vincent's University Hospital, Dublin 4, D04 T6F4, Ireland.
Background: CT thorax, abdomen and pelvis (CT-TAP) remains the standard in the identification of metastatic disease in patients with newly diagnosed breast cancer. In patients with proven micro and macro axillary nodal metastasis, the optimal radiological technique remains controversial. A consensus on which patients with axillary nodal disease should receive radiological staging for distant disease and how this should be performed is not currently available.
View Article and Find Full Text PDFCancer Biol Med
January 2025
State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Objective: Esophageal cancer (EC) ranks eighth among cancers in cancer-related deaths globally, and ~44% of new cases occur in China. We sought to describe the clinical characteristics and treatment landscape of EC in China before the approval of immunotherapy in 2020.
Methods: CHANNEL was a large, retrospective study using patient-level data from 14 hospitals/cancer centers across China, including adults initiating therapy for newly diagnosed EC (January to December 2018).
Br J Hosp Med (Lond)
December 2024
Department of Hematology, Hebei General Hospital, Shijiazhuang, Hebei, China.
Peripheral nerve injury affects some people with multiple myeloma; this condition can be brought on by the disease itself or by the treatments they receive. Such a complication increases patients' financial burden, causes treatment to be interrupted or delayed, and reduces treatment efficacy. However, opinions regarding the risk factors for peripheral neuropathy are currently divided.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!